<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04127656</url>
  </required_header>
  <id_info>
    <org_study_id>AL28</org_study_id>
    <nct_id>NCT04127656</nct_id>
  </id_info>
  <brief_title>Infants Fed an Amino Acid-based Formula</brief_title>
  <official_title>Symptom Changes in Infants Fed an Amino Acid-based Formula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To observe the effects of an amino acid-based formula on symptoms associated with food&#xD;
      allergies in infants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 16, 2019</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Food Allergy Symptom Improvement</measure>
    <time_frame>Baseline to Day 28</time_frame>
    <description>Parent Completed Symptom Diary</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Symptom Resolution or Reduction</measure>
    <time_frame>Baseline to Day 28</time_frame>
    <description>Parent Completed Symptom Diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Length</measure>
    <time_frame>Baseline to Day 28</time_frame>
    <description>Length-for-age z scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Weight</measure>
    <time_frame>Baseline to Day 28</time_frame>
    <description>Weight-for-age z scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study Formula Intake</measure>
    <time_frame>Baseline to Day 28</time_frame>
    <description>Parent Completed Intake Diary</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Food Allergy</condition>
  <arm_group>
    <arm_group_label>Amino Acid-Based Experimental Study Formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Not commercially available amino acid-based study formula</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Amino Acid-Based Experimental Study Formula</intervention_name>
    <description>Amino acid-based study formula; feed ad libitum</description>
    <arm_group_label>Amino Acid-Based Experimental Study Formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is judged to be in good health as determined from subject's medical history&#xD;
&#xD;
          -  Subject is from a full-term birth with a gestational age of 37-42 weeks&#xD;
&#xD;
          -  Subject's birth weight was â‰¥ 2490 g (~5 lbs. 8 oz.)&#xD;
&#xD;
          -  Subject has been documented to have CMPA and/or multiple food allergies, FPIES or&#xD;
             gastrointestinal eosinophilic disorders.&#xD;
&#xD;
          -  Subject is experiencing persistent feeding intolerance symptoms including any of the&#xD;
             following: regurgitation/vomiting associated with feeding (within 1 hour),&#xD;
             constipation, diarrhoea, hematochezia (blood in the stool), crying, gassiness (wind),&#xD;
             and/or skin rash/eczema.&#xD;
&#xD;
          -  Parent(s) confirm their intention to feed their infant study product during the study&#xD;
             period.&#xD;
&#xD;
          -  Parent(s) confirm their intention not to administer vitamin or mineral supplements to&#xD;
             their infant from enrolment through the duration of the study, unless instructed&#xD;
             otherwise by their healthcare professional.&#xD;
&#xD;
          -  Infant using medications (OTC medications for gas [wind]), home remedies (such as&#xD;
             juice for constipation), herbal preparations, prebiotics, probiotics or rehydration&#xD;
             fluids that might affect Gl tolerance may not be enrolled unless the parent agrees to&#xD;
             discontinue the use of these agents prior to enrolment or a healthcare professional&#xD;
             recommends their continued use.&#xD;
&#xD;
          -  Subject's parent(s) has voluntarily signed and dated an ICF, approved by an IEC/IRB&#xD;
             and provided applicable privacy regulation authorisation prior to any participation in&#xD;
             the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject is receiving steroids or antibiotics&#xD;
&#xD;
          -  Subject is tube-fed&#xD;
&#xD;
          -  Subject has received an amino acid-based formula&#xD;
&#xD;
          -  Subject has been diagnosed with: Short bowel syndrome, Inflammatory bowel disease,&#xD;
             Pancreatic disease, Protein maldigestion (malnutrition), Mast cell disorder&#xD;
&#xD;
          -  Subject is participating in another study that has not been approved as a concomitant&#xD;
             study by AN&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Kajzer, MS, RD, LD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen DeLuca, MS,RDN, LD</last_name>
    <phone>614-624-5455</phone>
    <email>kristen.deluca@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Adam Practice</name>
      <address>
        <city>Poole</city>
        <zip>BH15 4JQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton NHS Foundation Trust</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal London Hospital</name>
      <address>
        <city>Whitechapel</city>
        <zip>E1 1BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 11, 2019</study_first_submitted>
  <study_first_submitted_qc>October 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2019</study_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Food Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

